Showing results (891-900 of 1,795) with videos related to

Sort By:
Pageof 180
Mabs|July 6, 2019
Glycoform-resolved FcɣRIIIa affinity chromatography-mass spectrometrySteffen Lippold, Simone Nicolardi, Elena Domínguez-Vega, et al.
Mabs|June 4, 2019
Rapid global characterization of immunoglobulin G1 following oxidative stressYao Chen, Emma Doud, Todd Stone, et al.
Mabs|June 4, 2019
Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4Katherine Griffiths, Uli Binder, William McDowell, et al.
Mabs|March 16, 2022
CLEC5a-directed bispecific antibody for effective cellular phagocytosisVivekananda Kedage, Diego Ellerman, Mingjian Fei, et al.
Mabs|February 28, 2022
Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?Jingjing Zhang, Han Zhang, Litao Sun
Mabs|December 15, 2022
Restoring the biological activity of crizanlizumab at physiological conditions through a pH-dependent aspartic acid isomerization reactionFabian Bickel, François Griaud, Wolfram Kern, et al.
Mabs|May 2, 2015
Characterizing monoclonal antibody structure by carboxyl group footprintingParminder Kaur, Sara E Tomechko, Janna Kiselar, et al.
Mabs|May 12, 2015
Regulatory considerations in oncologic biosimilar drug developmentJudith C Macdonald, Helen Hartman, Ira A Jacobs
Mabs|April 20, 2010
The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regionsFiona A Harding, Marcia M Stickler, Jennifer Razo, et al.
Mabs|April 20, 2010
Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunizationRaquel Martín-Folgar, Gema Lorenzo, Hani Boshra, et al.
Pageof 180